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Abstract
During vertebrate axis extension, adjacent tissue layers undergo profound morphological
changes: within the neuroepithelium, neural tube closure and neural crest formation are
occurring, while within the paraxial mesoderm somites are segmenting from the presomitic
mesoderm (PSM). Little is known about the signals between these tissues that regulate
their coordinated morphogenesis. Here, we analyze the posterior axis truncation of mouse
Fgf3 null homozygotes and demonstrate that the earliest role of PSM-derived FGF3 is to
regulate BMP signals in the adjacent neuroepithelium. FGF3 loss causes elevated BMP sig-
nals leading to increased neuroepithelium proliferation, delay in neural tube closure and
premature neural crest specification. We demonstrate that elevated BMP4 depletes PSM
progenitors in vitro, phenocopying the Fgf3mutant, suggesting that excessive BMP signals
cause the Fgf3 axis defect. To test this in vivo we increased BMP signaling in Fgf3mutants
by removing one copy of Noggin, which encodes a BMP antagonist. In such mutants, all
parameters of the Fgf3 phenotype were exacerbated: neural tube closure delay, premature
neural crest specification, and premature axis termination. Conversely, genetically decreas-
ing BMP signaling in Fgf3mutants, via loss of BMP receptor activity, alleviates morphologi-
cal defects. Aberrant apoptosis is observed in the Fgf3mutant tailbud. However, we
demonstrate that cell death does not cause the Fgf3 phenotype: blocking apoptosis via
deletion of pro-apoptotic genes surprisingly increases all Fgf3 defects including causing
spina bifida. We demonstrate that this counterintuitive consequence of blocking apoptosis
is caused by the increased survival of BMP-producing cells in the neuroepithelium. Thus,
we show that FGF3 in the caudal vertebrate embryo regulates BMP signaling in the neuroe-
pithelium, which in turn regulates neural tube closure, neural crest specification and axis ter-
mination. Uncovering this FGF3-BMP signaling axis is a major advance toward
understanding how these tissue layers interact during axis extension with important implica-
tions in human disease.
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Author Summary
During embryological development, the vertebrate embryo undergoes profound growth in
a head-to-tail direction. During this process, formation of different structures within adja-
cent tissue layers must occur in a coordinated fashion. Insights into how these adjacent tis-
sues molecularly communicate with each other is essential to understanding both basic
embryology and the underlying causes of human birth defects. Mice lacking Fgf3, which
encodes a secreted signaling factor, have long been known to have premature axis termina-
tion, but the underlying mechanism has not been studied until now. Through a series of
complex genetic experiments, we show that FGF3 is an essential factor for coordination of
neural tube development and axis extension. FGF3 is secreted from the mesodermal layer,
which is the major driver of extending the axis, and negatively regulates expression of
another class of secreted signaling molecules in the neuroepithelium, BMPs. In the absence
of FGF3, excessive BMP signals cause a delay in neural tube closure, premature specifica-
tion of neural crest cells and negatively affect the mesoderm, causing a premature termina-
tion of the embryological axis. Our work suggests that FGF3 may be a player in the
complex etiology of the human birth defect, spina bifida, the failure of posterior neural
tube closure.
Introduction
Axis extension in vertebrate embryos requires the coordination of numerous genetic and mor-
phological processes within and between the three germ layers: the endoderm, mesoderm and
the ectoderm-derived neuroepithelium. This coordination requires numerous signaling factors
for regulation of key events that must occur in a proper sequence.
An example of this is the neuroepithelium, which undergoes morphological movements
that transform a sheet of cells into the neural tube. Underlying and driving this essential pro-
cess are a number of signaling pathways, genetic and epigenetic mechanisms and environmen-
tal cues [1–3]. Considering this complexity, it is understandable that neural tube defects
(NTDs) are among the most prevalent birth defects in the human population (1:1000) [4] and
quite a large number of mouse NTDmodels (exceeding 240) have been identified [5–7].
Neurulation during vertebrate axis extension is divided into primary and secondary phases.
During primary neurulation, the neural tube forms by folding of the neural plate so that the
two edges of the plate are spatially near allowing for fusion at the dorsal midline [8]. Closure
along the spinal axis initiates at the hindbrain/ spinal cord boundary and proceeds caudally,
ending with closure of the posterior neuropore in the trunk region. Failure to close the neuro-
pore results in spina bifida (Latin for “split spine”), which remains the most frequent type of
human NTD, despite a decrease in frequency after the mandatory addition of folic acid to
enriched grain products in the USA [9]. Spina bifida has a 1-year survival rate of 79 to 96%,
depending on race/ethnicity [9]; however, surviving patients often experience lifelong disabili-
ties and mortality increases into young adulthood [10].
Closure of the posterior neuropore marks the end of primary neurulation. Neural tube for-
mation caudal to this region occurs via the process of secondary neurulation, involving a mes-
enchymal to epithelial transition of cells within the tailbud to generate a tube [11,12]. These
cells reside within a region of the tailbud called the “chordoneural hinge” (CNH) that contains
not only neural tube progenitors but also cells that generate caudal somites and notochord
[13–15].
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Concomitant with axis extension and neurulation, is the formation of the neural crest: a
transient, migratory lineage that delaminates from the dorsal neural tube and forms various
cell types that include the melanocytes, craniofacial cartilage and bone, and peripheral and
enteric neurons/glia. The timing of trunk neural crest emigration has been shown to be con-
trolled by caudal FGF signals and rostral retinoic acid signals from the adjacent mesoderm
[16].
Human neurocristopathies, syndromes caused by dysregulation of the neural crest, occur as
often as NTDs [17,18], and there is a limited overlap of the two types of syndromes [17]. Like-
wise, there is a subset of mouse mutants where defects occur in both neural tube closure and
neural crest development [5]. These include mutations in components of the BMP signaling
pathway, demonstrating that the proper regulation of this pathway is essential to both events
[19–22]. In the caudal trunk, exogenous BMP will inhibit the necessary morphogenic move-
ments within the neuroepithelium, which are necessary for neuropore closure, while premature
closure occurs in Bmp2 null homozygotes [23]. However, after closure, BMP signaling is
required for neural crest delamination from this region. Both BMP4 and BMP7 will induce
caudal neural crest cell programs [24] and data from manipulation of the chick embryo sup-
port the idea that BMP4 in the dorsal neural tube is required for the delamination of caudal
neural crest [25–27]. Thus, dorsal BMP activity in the caudal neural tube must be countered
because it impedes neural tube closure but afterwards is required for neural crest development.
One way the vertebrate embryo carefully calibrates BMP activity in this region is by a balance
between BMPs and their antagonist, NOGGIN [25,26]. Consistent with this idea, Noggin null
homozygotes display both an open neural tube and excessive neural crest development [23,28–
30].
Here we demonstrate that FGF3 signals from the presomitic mesoderm (PSM) provide
another level of regulation of caudal neural tube BMP signaling. Multiple FGFs are expressed
in the presomitic mesoderm and we have recently demonstrated that both Fgf4 and Fgf8 can
each encode a classical activity known as the “wavefront” that prevents differentiation of the
PSM during somitogenesis [31]. Simultaneous inactivation of both of these Fgf genes, at vari-
ous embryonic timepoints, causes an AP axis truncation [31,32]; however, inactivation of
either of these Fgfs alone causes no apparent extension defect, demonstrating redundancy of
this system [31,33]. Furthermore mouse single gene inactivation studies demonstrate that of
the five other Fgfs expressed in the PSM (Fgf3, Fgf5, Fgf15, Fgf17, and Fgf18), only Fgf3 has a
requirement in axis extension (reviewed in [27]). Our studies reveal that the Fgf3 axis trunca-
tion is caused by an upregulation in BMP signals from the caudal neural tube and that these
signals also cause an increase in neuroepithelial proliferation, delay in neural tube closure and
premature neural crest formation.
Results
Fgf3 expression in the nascent mesoderm is required for normal axis
extension
Fgf3Δ/Δ (“Δ” = deletion and null) mice used in this study [34] have a shortened tail (Fig 1A)
similar to that in mice homozygous for the first Fgf3 null allele generated by Capecchi and
coworkers [35,36]. This defect is 100% penetrant, with variable expressivity in two parameters:
the total tail length (Fig 1A) and the axial position of the anterior-most (and therefore the earli-
est to develop) malformed vertebra (Fig 1B). To exclude the possibility that genetic background
may affect these parameters, in all genetic experiments described below, we always used litter-
mates for control genotypes (Table 1).
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To understand the Fgf3 phenotype, we first considered where the gene is expressed. Fgf3
transcripts have been detected in the nascent mesoderm starting in the primitive streak at E7.5
through E9.5 [37], before closure of the posterior neuropore around E10.0 [38]. We confirmed
Fig 1. Loss of Fgf3 causes variable anterior-posterior axis truncation and caudal malformation. (A) Dorsal view of three Fgf3mutants (Fgf3Δ/Δ) and
one littermate Fgf3 heterozygous (Fgf3 Δ/WT) control showing a variably truncated and sometimes “knotted” tail (bottom two samples) in mutants. (B) Skeletal
preparations of three E18.5 Fgf3mutants demonstrating the variable position of the first vertebral defect (arrows; Ca, caudal vertebrae.Dotted lines outline
unstained cartilage). (C) Wholemount in situ hybridization (WISH) assays for Fgf3 at the stage indicated. Fgf3mRNA is detected in the primitive streak (ps,
E7.5, E8.5) as well as in the presomitic mesoderm (E8.5–12.5) and tail bud (E9.5–12.5). Expression is absent at E13.5. An apparent dynamic domain of Fgf3
is observed in the anterior PSM (asterisks) (see S1 Fig). Fgf3 expression is confined to mesoderm and absent in the posterior neural tube (C”, with
approximate plane of section shown by dotted line in C’. NT, neural tube; psm, presomitic mesoderm, 24 ss); E7.5-E13.5 images taken at the same
magnification (scale bar, E13.5); images in C’ and C” taken at the samemagnification (scale bar, C”). (D-M) WISH assay for Uncx4.1, which stains the
somites, andMsgn1, which stains the caudal PSM, in mutants and littermate controls at the stages indicated. Caudal PSM (Msgn1 domain) is depleted at
E12.5 in mutants and E13.5 in controls.D-I are dorsal views; J-M are lateral views. Arrowhead inM indicates touchingUncx4.1 domains. Bars in F andG
indicate total PSM length, which is quantified in N. Note that a decrease in the amount of mutant PSM begins at 37 ss followed by a total loss of PSM around
54 ss, resulting with fewer somites in mutants. Error bars represent SEM; significance determined by two-tailed t-test.
doi:10.1371/journal.pgen.1006018.g001
Table 1. Experimental crosses used in this study.
Experimental Cross Experimental Genotype (Frequency) Control Genotype (Frequency)
Fgf3WT/Δ X Fgf3Δ/Δ Fgf3Δ/Δ (1/2) Fgf3WT/Δ (1/2)
Fgf3Δ/Δ; BakWT/Δ; BaxWT/Δ X Fgf3Δ/Δ; BakWT/Δ; BaxWT/Δ Fgf3Δ/Δ; BakΔ/Δ; BaxΔ/Δ (1/16) Fgf3Δ/Δ (1/16)
Fgf3Δ/Δ; BakΔ/Δ; BaxWT/Δ X Fgf3Δ/Δ; BakΔ/Δ; BaxWT/Δ Fgf3Δ/Δ; BakΔ/Δ; BaxΔ/Δ (1/4) Fgf3Δ/Δ; BakΔ/Δ (1/4)
Fgf3Δ/Δ X Fgf3Δ/Δ; NogLacz/WT Fgf3Δ/Δ; NogLacz/WT (1/2) Fgf3Δ/Δ (1/2)
Fgf3Δ/Δ; Bmpr1bWT/Δ* X Fgf3Δ/Δ; Bmpr1bWT/Δ* Fgf3Δ/Δ; Bmpr1bΔ/Δ* (1/4) Fgf3Δ/Δ* (1/4)
Note: all “Δ” (deletion) alleles are null alleles.
* Animals also contain Bmpr1a ﬂox/ﬂox; Rosa26 mtmg/mtmg; see Methods and Materials
doi:10.1371/journal.pgen.1006018.t001
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and extended these analyses and found that Fgf3 expression is maintained in the nascent meso-
derm, emerging from the primitive streak or tail bud, throughout development until axis exten-
sion ceases at E13.5 (Fig 1C); Fgf3 expression is restricted to the tail bud mesoderm and not
found in the adjacent neuroectoderm (Fig 1C’ and 1C”). We also noted that an Fgf3 expression
domain exists in the anterior presomitic mesoderm (PSM) that apparently oscillates because its
dimensions varied between embryos of the same embryonic stage (asterisks in Fig 1C and 1C’;
S1 Fig).
Given this oscillatory expression domain and the work we and others have published dem-
onstrating that different FGFs play essential roles controlling oscillatory activities during somi-
togenesis [31,32,39,40], we considered whether the Fgf3 axis defect might be due to
dysregulation of normal gene oscillations in the caudal embryonic axis. To address this, we
examined Hes7 expression, a key clock component that responds to FGF signals [31,41,42], in
mutant and control embryos from E10.5 to E10.75. We found that Hes7 expression oscillates in
Fgf3 null homozygotes in an approximately normal pattern although both the caudal somites
and the PSM were abnormally shorter in the anterior-posterior axis (S2 Fig).
We examined this size reduction in the mutant PSM and somites in more detail by simulta-
neously determining the expression of both Uncx4.1, which marks the posterior half of each
somite [43] andMsgn1, which marks the posterior PSM [44]. The total PSM is the area
between Uncx4.1 expression in the caudal-most somite and the posterior limit ofMsgn1
expression (black bars in Fig 1F and 1G). Furthermore, theMsgn1 expression domain is a read-
out of wavefront activity [45,46] and as such, regresses as the posterior axis extends, eventually
dwindling in the growing caudal axis and then disappearing as axis extension ceases [47]. In
the developmental time window we examined (E9.5- E13.5) control PSM length is highest at
~20 somite stage (ss) (about E9.25), rapidly decreases till ~28 ss (about E10.0), and then
remains relatively unchanged for the next 2 days (Fig 1D, 1F, 1H and 1N). Then on day E12.5
the amount of PSM declines rapidly so that by E13.5 noMsgn1 expression can be observed
because all PSM has been incorporated into somites, forming a total of ~64 somites (Fig 1J, 1L
and 1N). These changes in PSM length resemble those originally described by Tam [48]. Fgf3
mutants have comparable amounts of PSM from 20 ss (~E9.5) (compare Fig 1D and 1E) up to
37 ss (~E10.5) when they possess significantly less PSM (Fig 1N and compare Fig 1F and 1G)
and at E12.5 lose all PSM, a full day earlier than controls (Fig 1K). Because of this aberrantly
early PSM loss, in this genetic background, Fgf3mutants form an average of ~10 fewer somites
than control littermates (Fig 1N). The size and shape of the Fgf3mutant caudal somites are
also clearly smaller at E11.5 (compare Fig 1H and 1I). A consistent dorsal curve of the axis
causes the dorsal distance between somites to be shorter than the ventral distance (Fig 1K and
1M) and in some cases, the two Uncx4.1 domains are fused (arrowhead in Fig 1M). These
changes in mutant somite shape and number sufficiently account for the final vertebral defects
observed in adults (Fig 1A and 1B).
We explored whether these changes in somite morphology were preceded by changes in
dorsal-ventral (DV) somite patterning by examining expression of Pax1 and Pax3, [49,50].
This analysis revealed that DV patterning was not affected in Fgf3mutants (S3 Fig). Another
consideration is that the simultaneous loss of both Fgf4 and Fgf8 expression in the PSM affects
axis extension [31,32]. We found that expression of neither of these Fgf genes was affected at
stages preceding PSM loss (S4 Fig), however at stages when the PSM is reduced we did observe
a similar loss of Fgf8 expression as a consequence of tissue loss (inset C, D S4 Fig). In addition,
expression of Spry2 and Etv4, two “FGF-target” genes responsive to Fgf4 and Fgf8 [31,32], was
also not affected (S4 Fig). Thus FGF3 is not necessary for Spry2 and Etv4 expression, an obser-
vation that builds on our previous insight that FGF3 was not sufficient, when Fgf4 and Fgf8
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were inactivated, for the expression of these FGF target genes [31]. Therefore Fgf3 is uniquely
required for caudal axis extension, independent of Fgf4 and Fgf8 function.
Fgf3mutants display aberrant cell death in the tail bud region
Premature loss of Fgf3mutant PSM could be explained by a decrease in cellular proliferation
and/or an increase in cell death. We measured the rate of proliferation in the PSM at 28 ss and
34 ss and found there to be no difference between mutants and controls (S5 Fig). To determine
if there were any changes in cell death within the PSM we stained with LysoTracker Red, which
marks domains of cell death [51], in 28 ss (E9.5), 36 ss (E10.5), and 44 ss (E11.5) mutant and
control embryos. At 28 ss mutants and control littermates had a similar pattern of staining
with a scattering of LysoTracker Red-positive cells in the dorsal neural tube and surrounding
caudal end of the tail gut (Fig 2A and 2B). However, beginning around the 36 ss and continuing
through 44 ss, an aberrant domain of cell death is observed in the dorsal tail bud caudal to the
neural tube (Compare Fig 2D with 2C and 2F with 2E).
To more precisely locate this region of aberrant cell death we immunostained sagittally sec-
tioned mutants for cleaved-Caspase3 [52] and found that the aberrant cell death domain occurs
in the CNH region, where progenitors reside that give rise to the mesoderm during secondary
axis extension [13–15]. To examine the state of these progenitors, we took advantage of a
unique quality of Fgf8 expression that allows us to specifically label these cells. Although Fgf8
mRNA is found throughout the PSM, transcription only occurs in the tailbud progenitors that
generate the PSM (S6 Fig). As new mesoderm is formed from the progenitors, Fgf8mRNA per-
dures in the daughter cells, as they are displaced from this region and populate the PSM. Decay
of mature Fgf8 transcripts then generates the observed Fgf8mRNA expression gradient [53].
This observation demonstrates that the cells actively transcribing Fgf8 are the progenitors of
the PSM. Hence, whereas an exonic riboprobe marks both the PSM and its progenitors, an
intronic probe (Fgf8intron) can be used to label only the progenitors that are located within the
CNH (S6 Fig).
At 28 ss, prior to aberrant cell death, no difference was observed in the intronic Fgf8 staining
domain between Fgf3 homozygotes and littermate controls (Fig 2J and 2I). However, by 38 ss,
the Fgf8intron domain in mutants was reduced in the dorsal posterior tailbud (compare Fig 2L
with 2K) and was absent by 44 ss (compare Fig 2N with 2M), a day before the PSM is prema-
turely exhausted (Fig 1K and 1N). These data led us to initially hypothesize that Fgf3mutants
were losing PSM progenitors, and therefore PSM, due to aberrant cell death.
It is important to distinguish between the loss of the Fgf8intron signal that is the result of
the Fgf3 defect and reflects loss of PSM progenitors and the possible contribution of the loss of
FGF8 activity to the Fgf3 axis defect. As mentioned above, analysis of Fgf8 exon staining and
downstream FGF8 target genes indicates no loss of Fgf8 expression except that due to loss of
the PSM tissue (S4 Fig). This suggests no contribution of Fgf8 loss to the Fgf3 defect. To test
this directly, we used TCre [31,33] to inactivate Fgf8 in the gastrula mesoderm in an Fgf3 null
background and found that this early inactivation of Fgf8 had no effect on the Fgf3 defect (aver-
age number of caudal vertebrae: 20.9 for TCre; Fgf8flox/wt; Fgf3Δ/Δ, n = 7 vs. 22.0 for TCre;
Fgf8flox/Δ; Fgf3Δ/Δ, n = 6).
Restoration of cell survival in Fgf3mutants exacerbates the mutant
phenotype and reveals a neural tube defect
To determine if aberrant cell death was responsible for premature progenitor loss and hence
Fgf3 caudal defects, we sought to restore cell survival by generating Fgf3mutants that also
lacked Bak and Bax, which encode pro-apoptotic BCL-2 family members [54–56]. We scored
FGF3-BMP Signaling and Caudal Embryonic Morphogenesis
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Fig 2. Fgf3mutants have aberrant cell death of tailbud progenitors. LysoTracker Red staining of Fgf3mutants (B, D, F) and littermate Fgf3
heterozygous controls (A, C, E), showing a domain of cell death unique to the mutant tails beginning at 36 ss (E10.5) (white arrow, D) and continuing
through 44 ss (E11.5) (F); all images taken at the same magnification (scale bar, F). Cleaved caspase-3 staining (red) on a sagittally sectioned 38 ss (E10.5)
mutant tailbud showing aberrant cell death in the chordoneural hinge region (G, H; box indicates chordoneural hinge region,NT: neural tube,No: notochord,
GT: gut tube); images taken at the same magnification (scale bar, H). (I-N) WISH assay using a riboprobe specific to the nascent Fgf8mRNA: Fgf8intron,
marking the tailbud progenitor domain (black arrows), which is similar between Fgf3 heterozygous controls and Fgf3mutants at 28 ss (E9.5) (compare J to
I), diminished in Fgf3mutants beginning at 38 ss (E10.5) (compare L to K) and gone in Fgf3mutants by 44 ss (E11.5) (compareN toM).White arrowheads
in I-N indicate a domain of Fgf8intron expression at the end of the tailgut that is unchanged, thus functioning as an internal control. All views are lateral; all
images taken at the samemagnification (scale bar, N).
doi:10.1371/journal.pgen.1006018.g002
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the two parameters of the Fgf3 defect that we described above in Fig 1A and 1B: 1) the first ver-
tebral body (that is, the most anterior) to be defective and 2) the total number of caudal verte-
brae. To exclude genetic background as a factor that might affect variability in these
parameters, we intercrossed Fgf3Δ/Δ; BakΔ/wt; BaxΔ/wt mice to produce progeny that were triple
null for all three loci as well as controls that were only Fgf3 null homozygotes (Table 1).
Mice doubly homozygous null for Bak and Bax have no detectable cell death in the tailbud
and form normal caudal vertebrae (S7 Fig). Cell death is also absent in all tailbud tissues of
E10.5 Fgf3; Bak; Bax triple null homozygotes, including the dorsal neural tube, gut tube and
the aberrant PSM domain (compare Fig 3B, with 3A).
Remarkably, removal of Bak and Bax, rather than rescuing the Fgf3 defect, worsened it. The
dorsal curve of the posterior axis was more pronounced and occurred more anteriorly in com-
pound mutants at E10.5 (compare Fig 3B with 3A) as did the first vertebral defect at E18.5 (Fig
3I). The PSM progenitor domain, marked by the Fgf8intron signal, was further reduced in tri-
ple Fgf3; Bak; Bax E10.5 mutants (compare Fig 3D with 3C) and, likewise, the total number of
caudal vertebrae formed was significantly reduced (Fig 3I). Lastly, Fgf3; Bak; Bax triple null
homozygotes displayed a new defect not immediately apparent in embryos lacking only Fgf3:
an abnormally open neuropore (n = 3/5) (compare Fig 3F and 3F’ with 3E and 3E’). Moreover,
at E18.5 two of five Fgf3; Bak; Bax triple null homozygotes from this cross displayed a failure of
complete closure of the spinal arches of the sacral vertebrae (spina bifida occulta).
To generate such mutants at a higher frequency (one in four) we intercrossed Fgf3Δ/Δ; BakΔ/Δ;
BaxΔ/wtmice (Table 1) and found that of thirty E18.5 triple homozygotes, three had spina bifida
(compare S8B with S8A Fig). We then prepared skeletons from twelve such mutants without
spina bifida and most (nine) displayed spina bifida occulta (compare S8D and S8F Fig to S8C
and S8E Fig). To determine if altered proliferation affected the closure of the neural tube of these
mutants, we examined rate of proliferation in E9.5 (26–28 ss) and E10.5 (32–34 ss) triple mutant
neural tubes. We noted a trend of greater proliferation at the earlier stages in triple mutants but
no difference at the later stages (S5B Fig). Therefore we conclude that an increase in cell number
through a lack of cell death, and possibly through increased proliferation, leads to the observed
failure of neural tube closure. These defects led us to consider whether there were defects in neu-
ral tube closure of simple Fgf3mutants.
The earliest morphological defect in Fgf3 null homozygotes is a delay in
neural tube closure
The original characterization of the axis defect in Fgf3 null homozygotes found no phenotype
in neural tube closure at E11.5, although it was noted that such mutants had an abnormally
large neural tube at this stage [36]. We reexamined the Fgf3mutant neural tube at earlier devel-
opmental stages, motivated by our observations of the severe open NTDs in Fgf3 Δ/Δ; Bak Δ/Δ;
Bax Δ/Δmice (Fig 3F). Prior to 25 ss (E9.5), the width of mutant and littermate-control neural
tubes appeared similar (Fig 4C). However, at 25 ss the Fgf3 homozygous caudal neural tube
starts to appear abnormally wide (Fig 4A–4C). We assayed for cell proliferation in Fgf3
mutants and controls at 26 ss and found that, indeed, Fgf3mutants had an increase in the rate
of proliferation (Fig 4D–4F). Similar to Fgf3 Δ/Δ; Bak Δ/Δ; Bax Δ/Δmutants the change in prolif-
eration detected at E9.5 was not observed at E10.5 (32–34 ss, S5 Fig).
To determine exactly when the Fgf3mutant neural tube closes, we injected India ink into
the neural tube at about the position of the third somite rostral to the PSM; in embryos with an
open neuropore, the ink is easily viewed escaping the neural tube lumen (Fig 4G). Such experi-
ments revealed that neuropore closure begins around 27 ss in control embryos but is delayed
by about 1 somite stage (2 hours) in the Fgf3mutant (Fig 4G). Because this defect is the earliest
FGF3-BMP Signaling and Caudal Embryonic Morphogenesis
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observed and occurs prior to defects in axis extension (Fig 1), it is the primary Fgf3mutant
phenotype. As development proceeds, the mutant neural tube remains abnormally large (Fig
4C) but the posterior neuropore closes in most mutant embryos; we have observed occasional
individuals with an open neuropore at E10.5 (Fig 4H).
NTDs can be affected by diet and environment [1]. In humans, dietary folic acid (FA) intake
during pregnancy has been shown to reduce the occurrence of human NTDs [57]. In mice, the
effect of FA supplementation has been explored in twenty-three genetic models to date where
it reduced NTD occurrence in seven mutants [58–62], had no effect in twelve mutants
Fig 3. Blocking cell death increases severity of Fgf3mutant malformation. LysoTracker Red staining of Fgf3 Δ/Δ; Bak Δ/Δ; Bax Δ/Δ (“triple”) mutants (B)
and littermate Fgf3 Δ/Δ embryos (A), show a rescue of aberrant cell death in triple mutants (solid arrow in A indicates domain of cell death and dotted arrow
inB shows domain of restored cell survival, bracket inA indicates normal domain of cell death in the dorsal neural tube). WISH assays for the markers
indicated (C-F). Fgf8intron expression showing a more severe loss of tailbud progenitors (black arrows, D) in triple mutants compared to controls (C). (F, F’)
Dorsal view and transverse section showing a lack of neural tube closure in triple mutants (n = 3/5; compare to control (E, E’). Relative position of sections in
E’ and F’ indicated by dotted-white lines in E and F. Note thatMsx1was stained to saturation. Skeletal preparations of triple mutants (H) and littermate Fgf3
mutants (G) at E18.5 demonstrating that triple mutants have an anterior shift of the first vertebral defect (Ca, caudal vertebrae) and a more severe truncation,
quantified in I. (I) Histogrammodeling the caudal vertebral column: elements labeled “S” or “C” represent sacral and caudal vertebrae, respectively. The AP
position of the first vertebral defect (red) and total number of vertebral elements (blue) are as shown for each genotype. For Fgf3 Δ/Δ; Bak Δ/Δ; Bax Δ/Δ
mutants, n = 3 and for Fgf3Δ/Δmutants, n = 8. Error bars represent SEM; significance determined by two-tailed t-test. Images A-F are taken at the same
magnification (scale bar, F) and E’-F’ are taken at the samemagnification (scale bar, F’).
doi:10.1371/journal.pgen.1006018.g003
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Fig 4. Fgf3mutants have defects in neuropore closure.Dorsal view of WISH assay for Sox2 stained posterior neural tubes showing a widened neuropore
in Fgf3mutants (B, bracket) compared to littermate Fgf3 heterozygous controls (A, bracket) at 25 ss, quantified inC. (C) Measurements of posterior neural
tube width at various stages demonstrating that the Fgf3mutant neural tube is first abnormally widened at the 25 ss (** = p< 0.005, 26–29 ss; * = p< 0.04;
significance determined by two-tailed t-test.). Phospho-histone H3 staining showing increased proliferation in mutant neuroectoderm (E, compared to control
D) quantified in F. Error bars represent SEM, statistical significance determined by two-tailed t-test (NE: neuroepithelium). (G) Injection of ink into the neural
tube (position of needle insertion indicated bywhite arrowheads) of Fgf3 heterozygous control and Fgf3mutant 25–29 ss embryos reveals a significant
delay in closure of mutant neural tube (27 ss) (asteriskmarks ink from open neuropore). Neural tube closure is complete in all mutants and controls by 29 ss;
statistical significance determined by n-1 two proportions test. (H) Dorsal view of WISH assay forMsx1mRNA (stained to saturation) shows failure of neural
tube closure in an Fgf3mutant at 10.5.
doi:10.1371/journal.pgen.1006018.g004
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[59,61,63–66] and either increased embryonic lethality or induced a more complicated
response in four mutants [61,67,68]. To test if the Fgf3 phenotype is folate-sensitive we crossed
Fgf3mutant heterozygotes to homozygotes, and intraperitoneally injected pregnant dames at
E7.75 with FA. Such injections had no effect on mutant neural tube closure at E9.5 (Fgf3 het-
erozygote: average width: 0.882, n = 3; Fgf3mutant: average width: 1.887, n = 3). However, at
E18.5 only 5/21 (24%) mutants were present instead of the expected 50% (which indeed we
observed in uninjected control experiments), suggesting that FA injections caused embryonic
lethality of homozygotes. Thus Fgf3 apparently falls into the gene subset wherein FA treatment
causes embryonic lethality of homozygous null mutants [61,67,68].
BMP signals are increased in the caudal regions of the Fgf3mutant
neural tube
BMP activity inhibits morphological movements necessary for neural tube closure. Bmp2,
Bmp4 and Bmp7 are all expressed in the dorsal neural tube at the time of posterior neuropore
closure with Bmp4 and Bmp7 expression occurring rostral to the posterior neuropore
[19,23,69]. Noggin, which encodes a BMP antagonist, is specifically expressed in the caudal
regions of the developing neural tube, inhibiting BMP activity and thus allowing closure of the
posterior neuropore [1,70].
We found that neural tube-specific Noggin expression was unchanged in Fgf3mutants start-
ing at 28 ss, when the posterior neuropore is closing, as well as later stages (S9 Fig). However,
we found that Bmp4 expression was initiated prematurely in the Fgf3mutant caudal neural
tube at 24 ss (Fig 5A–5B’), and remained aberrantly upregulated and extended caudally from
28 ss through 34 ss (Fig 5C, 5D, 5I, 5J and 5K). At 28 ss expression of Bmp7 was also increased
and shifted caudally in mutants (Fig 5E, 5F and 5I). To determine the outcome of BMP activity
in mutant neural tubes, we assayed for expression ofMsx1, a downstream BMP target gene
[71–73]. In all Fgf3mutants,Msx1 expression in the dorsal neural tube was upregulated and
shifted caudally (compare Fig 5G, 5H, 5I, 5L and 5M).
Neural Crest is prematurely specified in the caudal regions of the Fgf3
mutant neural tube
Neural crest migration within the embryonic trunk is thought to be triggered by BMP4-depen-
dent WNT1 activity [74]. Therefore, based on our observation that BMP activity was preco-
ciously upregulated in the absence of Fgf3, we asked whether trunk neural crest specification
was affected in these mutants. We found that the caudal limit ofWnt1 expression was extended
at 30 ss and remained upregulated through 36 ss (Fig 6A–6D). We also examinedWnt3a
expression, which is also a marker of caudal neural crest as well as the tailbud PSM [74]. We
foundWnt3a expression, likeWnt1, was notably upregulated in the mutant dorsal neural tube
from 28 ss through 34 ss (Fig 6E–6H). Interestingly, we found no change in the PSM domain
ofWnt3a in these samples, suggesting that altered WNT signals from this region do not cause
the Fgf3 defect (Fig 6E–6H).
To further examine neural crest development in Fgf3mutants we assayed for expression of
Snai1 (neural crest specification), Foxd3 (premigratory and migratory neural crest) and Sox10
(migratory neural crest) [30,75,76,77]. The caudal limit of Snai1 expression was extended in
mutants, suggesting premature specification of neural crest in the absence of Fgf3 (Fig 6I and
6J). This idea was confirmed by a caudal extension of both premigratory and migratory neural
crest in mutants, as indicated by Foxd3 and Sox10 expression at all stages examined (Fig 6K–
6P). We then examined the anatomy of caudal dorsal root ganglia, which are derived from the
neural crest, in E11.5 mutants by immunostaining for Neurofilament1. This analysis revealed
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no changes between mutant and littermate controls (S10 Fig). Therefore we conclude that the
increase in BMP activity in the caudal dorsal neuroepithelium of Fgf3mutants causes a prema-
ture specification of neural crest, but without an overall increase in neural crest formation.
Increased BMP activity causes the axis truncation defect in Fgf3
mutants
We noted thatMsx1 expression in Fgf3mutants occurred in the PSM progenitor domain at
34 ss (compare Fig 5M with 5L), suggesting that these cells were receiving BMP signals (a simi-
larMsx1 expression domain occurs in normal controls, but about a day later, as shown in
Fig 5. Fgf3mutants have upregulated BMP-signaling in the neural tube. Lateral view (A, B) or dorsal view (A’, B’, focusing on cross-section of neural
tube) of WISH assay reveals that Bmp4 expression initiates within the dorsal neural tube of Fgf3mutants at 24 ss (B, B’, arrow) but not in controls (A, A’)
and is further increased and posteriorly expanded in mutants at 28ss (D, arrows indicate posterior limit of expression, compare to C). (A-M) are lateral views
of WISH using the probe, genotype and stage indicated. Bmp7 expression shows a caudal expansion of expression domain in Fgf3mutants (F, arrows
indicate posterior limit of expression, compare to E).Msx1 is also upregulated and posteriorly shifted in Fgf3mutants (H, compare toG). Note thatMsx1
WISH was performed for a relatively short period to reveal qualitative differences in intensity between genotypes. (I) qPCR using primers specific to Bmp4,
Bmp7, orMsx1 confirming upregulation in neural tube tissue; error bars represent SEM, graph is representative of at least three experiments. At 34 ss Bmp4
andMsx1 expression continues to be caudally expanded in Fgf3mutants (K and M compare to J and L). At this stageMsx1 expression occurs in the PSM
(arrowhead inM). Images A-H are taken at the same magnification (scale bar, H) and J-M are taken at the samemagnification (scale bar, M).
doi:10.1371/journal.pgen.1006018.g005
FGF3-BMP Signaling and Caudal Embryonic Morphogenesis
PLOS Genetics | DOI:10.1371/journal.pgen.1006018 May 4, 2016 12 / 30
S11 Fig). Because this is about the time when the mutant PSM progenitor domain begins to
diminish (Fig 2L), we asked whether increased BMP signals cause this loss. To test this, we
grafted BMP4-soaked beads in the wildtype neural tube just rostral to the progenitor domain
and determined that we could readily induce expression of the BMP target geneMsx1 (com-
pare Fig 7B with 7A). In all such cases (n = 5), we found a loss of Fgf8intron signals (compare
Fig 6. Fgf3mutants have caudally expanded neural crest.WISH assay for markers indicated (A-P, Uncx4.1 expression marks somites) showing
expanded neural crest in Fgf3mutants (B, D, F, H, J, L, N, P) compared to stage matched littermate controls (A, C, E,G, I, K, M, O). Bracket K and L
indicates distance between posterior limit of Foxd3 expression and end of NT; red arrows indicate caudal limit of migratory neural crest cells; black arrows
indicate caudal limit of premigratory neural crest in the dorsal-midline; asterisks indicate last formed somite. All images taken at the samemagnification
(scale bar, P).
doi:10.1371/journal.pgen.1006018.g006
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Fig 7D with 7C), suggesting that increased BMP activity within the progenitors was sufficient
for the loss of this population, precipitating shortening of the axis.
To test our hypothesis that an increase in BMP signaling was the cause of these defects in
vivo we assessed whether they are worsened by increasing BMP signaling or improved by
decreasing BMP signaling. We did this genetically, by generating Fgf3 homozygous embryos
and animals that also carried mutant alleles in key BMP signaling genes.
One of these genes is Noggin (Nog), which encodes the BMP antagonist that plays an essen-
tial role in the normal inhibition of BMP signals necessary for posterior neuropore closure. To
evaluate the consequences of increased BMP signaling, we generated Fgf3 null homozygotes
that are also heterozygous for a Nog null allele (NoglacZ/wt) [28] (Table 1). It is important to
note that such Nog null heterozygotes are phenotypically normal in a wildtype background.
Fig 7. Exogenous BMP reduces PSM progenitors.WISH assay for markers indicated on tail explant cultures with a BSA soaked bead (A, C) or BMP4
soaked bead (B, D) inserted into the posterior neural tube of 30 ss wildtype embryos (ForA-D, n = 4/4, 5/5, 3/4, 5/5 respectively).
doi:10.1371/journal.pgen.1006018.g007
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Msx1 transcripts were more readily detected within the neural tube of Fgf3Δ/Δ; NoglacZ/wt
embryos, when compared to littermates that were simple Fgf3 null homozygotes, demonstrat-
ing the expected relative increase in BMP signaling (S12 Fig). At 27 ss, these compound
mutants, when compared with control Fgf3 null homozygotes, displayed a neural tube that was
on average 35% wider (compare Fig 8B with 8A, quantified in 8C, S12 Fig). This worsening of
the neural tube defect is accompanied by an increase in proliferation within the neuroepithe-
lium (Fig 8D). Likewise all other Fgf3 defects are exacerbated in these compound mutants: the
PSM progenitor domain, marked by the Fgf8intron signal, is further decreased (compare Fig
8F with 8E) and the caudal limit of neural crest markers is further expanded (compare Fig 8H
with 8G). These aggravations of the Fgf3 null defects in early embryos prefigured changes in
later development: in E18.5 Fgf3Δ/Δ; NoglacZ/wt embryos, there was an anterior shift in the posi-
tion of the first defective vertebra as well as an overall reduction in the total number of caudal
vertebrae (compare Fig 8J with 8I, quantified 8K). Therefore, increasing BMP signaling
increases the severity of the NTDs, neural crest expansion and PSM loss in Fgf3mutants.
We then asked the converse question: does reducing BMP signaling improve the Fgf3
defects? To address this, we generated Fgf3 null homozygotes that were also lacking Bmpr1b
[78](Table 1), which is expressed in the developing neural tube [79] and encodes a type-1
BMP-receptor. Mice lacking Bmpr1b have no obvious neural tube or axis extension/vertebral
defect [80].
We confirmed that BMP signaling was decreased in Fgf3Δ/Δ; Bmpr1bΔ/Δ embryos by com-
paring the intensity ofMsx1 expression in such double mutants to that found in littermates
that were null only for Fgf3 (S12 Fig). At 28 ss double mutants displayed a neural tube that was
significantly narrower, and therefore more normal, than that found in Fgf3 homozygotes (com-
pare Fig 9B with 9A, quantified 9C, S12 Fig) with a corresponding reduction in cellular prolif-
eration within the neuroepithelium (Fig 9D). We observed a definite restoration of the PSM
progenitor domain at 34 ss (compare Fig 9F with 9E). Likewise, the caudal limit of neural crest
formation was also restored to a more normal level at 34 ss (compare Fig 9H with 9G). At
E18.5 we observed a significant shift toward normality in Fgf3Δ/Δ; Bmpr1b Δ/Δmutants in both
the position of the first vertebral defect and the total number of caudal vertebrae (compare Fig
9J with 9I, quantified in 9K). Thus, these data support our hypothesis that BMP signals from
the neural tube in Fgf3 null homozygotes cause abnormal axis extension and reducing BMP
signaling in these mutants partially rescues all the phenotypic defects.
Discussion
Fgf3 holds a special place in the history of genetics as the first non-selectable locus to be inacti-
vated in the mouse by gene targeting [81]. Mice lacking Fgf3 have defects in ear and tail devel-
opment; although much has been studied about the former phenotype, heretofore little beyond
the initial characterization has been analyzed regarding the tail defect [35,36]. Our findings are
summarized in Fig 10. We demonstrate that the tail defect is preceded, at E9.5, by premature
initiation of BMP signals (both Bmp4 and Bmp7) from the dorsal neural tube. This has two
immediate consequences within the neuroepithelium: a delay in closure of the posterior neuro-
pore and abnormal expansion of neural crest during primary neurulation.
Increased Bmp expression in the dorsal neural tube can be expected to increaseWnt gene
expression, and through WNT action, increase both cellular proliferation and neural crest
[19,23,26,27,74,82]. Consistent with this, we observe both an increase inWnt1 andWnt3a in
the caudal neural tube and an increase in proliferation in the Fgf3 neural tube. Excessive prolif-
eration has been associated with neural tube closure defects [83,84] not surprisingly given the
complex patterns of proliferation and cell movement that accompany neural tube closure [85].
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When we genetically ratchet BMP signaling up or down, which increases or decreases Fgf3 neu-
ral tube defects, we observe a concomitant increase or decrease, respectively, in proliferation.
Hence increased proliferation, through increased BMP activity, may lie at the heart of the Fgf3
neural tube phenotype.
At E10.5, 24 hours after BMP signals have increased, we observe the first evidence of an axis
truncation: loss of PSM progenitor cells (a reduction of the Fgf8intron domain) and a shorter
PSM (a reduction in theMsgn1 expression domain). These changes occur during secondary
axis formation; thus the Fgf3 phenotypes straddle primary and secondary neurulation and axis
formation. We show that exogenous BMP4 is sufficient to reduce the progenitor domain of the
PSM. Furthermore, just as our genetic manipulations of BMP signaling in Fgf3mutants affect
neural tube phenotypes, they likewise affect axis extension defects, either increasing them
when one Noggin allele is removed or decreasing them when Bmpr1b is inactivated. One way
Fig 8. Increased BMP-signaling in Fgf3mutants worsens axis truncation. (A, B, E-H) WISH assays for probe and genotype shown. (A, B) are dorsal
views; (E-H) are lateral views. Fgf3Δ/Δ; NogLacz/wtmutants have a wider NT at 27 ss compared to Fgf3Δ/Δ littermate controls, (B compare to A; black
brackets indicate measurement of NT width, quantified in C), an increase in neuroectoderm proliferation as measured by phospho-histone H3 staining (D,
26–27 ss, n = 3 each, percentage represents positive nuclei per total nuclei), a further loss of tailbud progenitors at 37 ss (F, compare to E, black arrows
denote tailbud progenitor domain) and a caudal expansion of neural crest at 33 ss (H compare toG; red arrows indicate posterior limit of expanded neural
crest and somites are marked byUncx4.1 expression). Skeletal preparations of E18.5 Fgf3Δ/Δ; NogLacz/wtmutants (J) and littermate Fgf3Δ/Δmutants (I)
showing an increase in severity of axis malformation and truncation in the compound mutant (Ca: caudal vertebra, marking most anterior vertebral
malformation); (K) Histogram is similar to that described in Fig 3. For Fgf3Δ/Δ; NogLacz/wtmutants, n = 9 and for Fgf3Δ/Δmutants, n = 12. Error bars represent
SEM; significance determined by two-tailed t-test. Images in A, B, E–H were taken at the samemagnification (scale bar, H).
doi:10.1371/journal.pgen.1006018.g008
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to look at Fgf3mutants is that they provide a genetic background that is sensitized to differ-
ences in BMP signaling.
Does FGF3 signal directly to the neural tube?
Although our data supports a model in which FGF3 regulates BMP signals in the neuroepithe-
lium, this regulation could be achieved through FGF3 signaling directly to the neuroepithelium
or indirectly through an intermediate. While the current study does not conclusively prove
either of these possibilities, we favor the former idea (direct signaling). This is because we find
no evidence FGF3 signals to the PSM, regulating another factor that signals to the neural tube,
e.g. there is no reduction in the expression of the known FGF-target genes Spry2 or Etv4 within
the PSM of Fgf3mutants (S4 Fig). We have previously published data demonstrating that these
Fig 9. Reduction of BMP-signaling in Fgf3mutants partially rescues axis extension. (A, B, E-H) WISH assays for probe and genotype shown. (A, B)
are dorsal views; (E-H) are lateral views. Fgf3Δ/Δ; Bmpr1bΔ/Δ compound mutants, compared to Fgf3Δ/Δmutants show a narrower, more normal neural tube at
28 ss (B compare to A; black brackets indicate measurement of NT width, quantified in C), a decrease in neuroectoderm proliferation as measured by
phospho-histone H3 staining (D, 26–27 ss, n = 3 each, percentage represents positive nuclei per total nuclei), an increase in tailbud progenitors (F compare
to E; black arrows denote tailbud progenitor domain) and a rostrally shifted, more normal, posterior limit of neural crest cells at 34 ss (H compare toG; red
arrows indicate posterior limit of neural crest expansion and somites are marked byUncx4.1 expression). Skeletal preparations of E18.5 Fgf3Δ/Δ; Bmpr1bΔ/
Δmutants (J) and littermate Fgf3Δ/Δmutants (I) showing a shift toward normality in both axis malformation and truncation in the compound mutant (Ca: caudal
vertebra, marking most anterior vertebral malformation); (K) Histogram is similar to that described in Fig 3. For Fgf3Δ/Δ; Bmpr1bΔ/Δmutants, n = 8 and for
Fgf3Δ/Δmutants, n = 10. Error bars represent SEM; significance determined by two-tailed t-test. Images in A, B, E–H were taken at the samemagnification
(scale bar, H).
doi:10.1371/journal.pgen.1006018.g009
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FGF target genes are downregulated when Fgf4 and Fgf8 are inactivated within the PSM,
despite Fgf3 expression, indicating that FGF3 is not sufficient for their expression [31].
Direct FGF3 signals to the neural tube may occur through FGFR1 or FGFR2, as mutations
of either result in neural tube malformations. Fgfr1 homozygous null development arrests prior
to neural tube closure [86,87], but chimeric embryos with contributions of Fgfr1 null cells in
the posterior neural tube displayed spina bifida and kinked tails [88]. Furthermore, embryos
that carry FGFR1 mutations that have abrogated signal transduction to the MAPK and PI3K
pathways have NTDs [89]. Equally compelling is the case for FGFR2. The IIIb isoform of
FGFR2 binds FGF3 and is preferentially expressed in epithelia, such as the neuroepithilium
[90]. Embryos homozygous for mutations that delete only this Fgfr2 isoform have tail defects
identical to those in Fgf3mutants (neural development was not examined in these studies)
[91,92]. Neural tube-specific deletions of these receptor genes are needed to explore whether
FGF3 signals directly to the neuroepithelium.
Fig 10. Model and timeline of phenotypes. (A) Timeline of phenotypes due to loss of Fgf3, indicating onset
and duration of observed increased BMP signaling in the neural tube, aberrant neural tube width and caudal
neural crest expansion, loss of tailbud progenitors (indicated by Fgf8intron staining), and decreased PSM.
Red “X” indicates premature loss of tailbud progenitors (Fgf8intron lost around ~48 ss as opposed to normal
loss at >55 ss), and premature loss of PSM. NCC, neural crest cells;NT, neural tube; PSM, presomitic
mesoderm. (B) Model of FGF3 signaling from the PSM to limit BMP signaling in the neural tube, which
positively affects neural crest cell specification, and negatively affects neural tube closure and tailbud
progenitors in the mesoderm.
doi:10.1371/journal.pgen.1006018.g010
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Fgf3 signaling and genetic redundancy
Although Fgf3 expression is continuous in the emerging mesoderm starting at E7.5 (this study
and [37]), the earliest consequence of Fgf3 loss is not observed until 24 ss (about E9.5). There-
fore if an earlier FGF3 requirement from this domain exists, it must be redundant with another
FGF(s). Genetic studies in the mouse reveal that FGF3 shares function with FGF8 and FGF10
in inner ear development [34,93–95], with FGF10 in cardiovascular development [96] and with
FGF8 in pharyngeal morphogenesis [97]. Candidate Fgf genes expressed within or near the
PSM that may function along with Fgf3 include Fgf4, Fgf5, Fgf8, Fgf15, Fgf17 and Fgf18 [98],
with Fgf4 and Fgf8 arguably being the strongest candidates based on their requirements in axis
extension [31,32]. We have recently published that Fgf3 and Fgf4 are functionally redundant
for mesoderm maintenance in the tailbud during secondary axis formation; however we do not
see additional defects in mesoderm or neural tube patterning in the primary axis [99]. In the
present work we demonstrate that no functional redundancy exists between Fgf3 and Fgf8.
We propose that Fgf4 and Fgf8 are required throughout axis extension for PSM gene expression
andmaintenance whereas FgF3 is required during a window during the transition between primary
and secondary axis extension for neuroepithelium gene expression and normal morphogenesis
through BMP action. In support of this idea, expression of FGF target genes in the PSM fails when
Fgf4 and Fgf8 are inactivated [31,32], even in the presence of persistent Fgf3 expression [31,32].
Although Boulet and Capecchi found neural tube defects when Fgf4 and Fgf8were inactivated, it is
unclear whether these defects were due to a primary or secondary effect of this phenotype. Further-
more, Boulet and Capecchi found that expression ofWnt3a, the only neural crest marker in their
study, was not upregulated in the neural tube [31,32], as we observe in Fgf3mutants (Fig 6).
Cell death in neural tube closure and axis extension termination
We discovered the neuropore closure defect in Fgf3mutants because it was dramatically exac-
erbated in embryos lacking the pro-apoptotic factors BAK and BAX in which apoptosis was
abolished. In normal development, cells at the neural ridges undergo apoptosis before and after
neural tube closure [100–102]. Whether this apoptosis is required for normal neural tube clo-
sure is somewhat controversial. Inhibiting apoptosis with the pan-caspase inhibitor, zVAD–
fmk, causes a failure of neural tube closure in avians [102] but not in mice [103]. Although
mice lacking genes that encode intrinsic apoptotic factors such as Casp3, Casp9 or Apaf1 have
neural tube closure defects [104–106], Copp and coworkers have found that the forebrain and
spinal regions of the neural tube close in Casp3 and Apaf1mutants [103]. Conflicting data con-
cerning the requirement for these factors may be explained by sensitivities of these defects to
genetic background [104]. Also, the requirements for apoptosis may be subtle; Yamaguchi et al
demonstrated that when closure occurs in Apaf1 and Casp3mutants, it does so with delayed
kinetics [101], which is what we observe in Fgf3 null homozygotes.
Surprisingly, these defects in Fgf3mutant neural tube closure were worsened upon abrogat-
ing cell death when we additionally deleted BAK/BAX function. In these Fgf3; Bak; Bax triple
null mutants, not only was the abnormal PSM cell death prevented, but normal cell death in
the dorsal neural tube was also inhibited (Fig 3A, bracket). This may result in retention of neu-
ral BMP–expressing cells, which, together with enhanced Bmp expression due to a lack of Fgf3,
causes overall high BMP levels causing the observed severe open NTD. Indeed, we find higher
Bmp4 expression in the dorsal neural tube of Fgf3; Bak; Bax triple null homozygotes compared
to simple Fgf3mutants (S13 Fig). Furthermore, there are increased migratory and premigratory
neural crest cells in the caudal neural tube of these compound mutants (S13 Fig), consistent
with the hypothesis of an increase of BMP signals; this interesting observation clearly warrants
further study.
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One question our data raises is whether the BMP-mediated loss of PSM progenitor cells in
Fgf3mutants is an acceleration of a process that occurs during normal axis termination. Prior
to normal termination of the axis, PSM-specific Fgf3 expression is downregulated (Fig 1C) and
BMP signaling increases in the PSM progenitor domain of wildtype embryos (as noted by
expression ofMsx1 as shown in S11 Fig). This is consistent with the idea that an FGF3-BMP
signaling axis may terminate anterior-posterior extension. Genetic proof of this hypothesis
would be the production of mice with longer tails due to the inactivation of gene(s) encoding
BMP-signaling components. Although we observe no such effect in Bmpr1b null homozygotes
(the average number of caudal vertebrae was 30 in both Bmpr1bΔ/Δ, n = 4, and Bmpr1bwt/wt,
n = 3), other candidate genes remain to be explored.
In chick and fish embryos, current models of axis termination propose that a downregulation
of FGFs andWNTs and rising retinoic acid (RA) levels lead to death of the PSM progenitors
[107–111]. However, experiments in the mouse suggest that axis termination occurs in the
absence of RA [112]. Furthermore, axis truncations due to PSM-specific inactivation of Fgfr1 or
Fgf4/Fgf8 occur without changes in RA levels [32,39]. Whatever the signals involved, our data
suggest that, at least in the mouse, cell death is not required for PSM progenitor loss, either nor-
mally during axis extension or prematurely in Fgf3mutants, because we find that if we inhibit
apoptosis by Bak/Bax inactivation, axis termination still occurs in both cases (S7 Fig, Fig 3).
Potential FGF3 role in human neural tube closure defects
Characterization of mouse tail mutants have led to insights into human syndromes affecting axis
extension. For example, mutations in the T locus, which cause a short tail in mice [113], are asso-
ciated with spina bifida and vertebral malformations in humans [114,115]. Therefore, we specu-
late that human FGF3mutations may also contribute to abnormal neural tube closure or vertebral
malformation. This would be consistent with Fgf3 targeted mouse alleles, which model defects in
human tooth and ear development where FGF3mutations cause congenital deafness, microtia,
and microdontia. (<http://omim.org/entry/164950?search=fgf3&highlight=fgf3>http://omim.
org/entry/164950?search=fgf3&highlight=fgf3).
In support of this idea, a genomewide screen for human NTDs found linkage at regions of
chromosome 10 (10q25.3) that include FGFR2 [116], which, as discussed above, encodes a likely
FGF3 receptor. Interestingly, Hillbertz et al suggested that mutations within the region of chro-
mosome 11 (11q13) that contains the closely linked genes, FGF3, FGF4 and FGF19, may cause
human NTDs based on their finding that a duplication of this region causes the hair ridge and
predisposition to dermoid sinus in Ridgeback dogs [117]. Dermoid sinus is caused by an incom-
plete separation of the neuroepithelium and ectoderm during neural tube closure and, in
humans, is often associated with spina bifida occulta [118]. We suggest that FGF3may be an
important gene in this region required for normal neural tube closure and caudal development.
Materials and Methods
Ethics statement
Mice were treated in accordance with the recommendations in the Guide for the Care and Use of
Laboratory Animals (National Academies Press; 8th edition). The protocol was approved by the
Animal Care and Usage Committee of NCI-Frederick (NIH) (Animal Study Proposal: 11–069).
Mouse lines
Mice were kept on a mixed background. Crosses were performed as described in Table 1,
wherein the female genotype is listed on the left side of the cross and male genotype on the
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right. Genotyping was performed as previously reported for the following alleles: Fgf3Δ [34],
BakΔ; BaxΔ [56], NogginLacz [28], Bmpr1aflox [119] Bmpr1bΔ [78], Rosa26MTMG [120]. One
exception is that we used the following primers to detect the Bax Δ allele: (5’- CAA CTC CTA
CCG CAA GTC CTG G-3’ and 5’- GAA CCC TAG GAC CCC TCC G-3’). All Fgf3Δ/Δ;
BmpR1bΔ/Δ and littermate control mice (Fig 8) also carried BmpR1aflox/flox, which, if unrecom-
bined, has wildtype activity, [119] and Rosa26MTMG/MTMG [120]. Neither these progeny nor
their parents contain a Cre transgene or allele and therefore these alleles had no phenotypic
consequence.
Whole mount in situ hybridization, skeletal preparations and cell death
analysis
Whole mount in situ hybridization was performed as previously described [31]. In all cases,
control and experimental embryos were processed in the same tubes throughout the procedure.
The Fgf8intron probe was constructed using the primers: 5’-GGAATTC ACGCAGTCCTT
GCCTTTGCCG-3’ and 5’- GGAATTCATCTGCATGAACAAGAAGG-3’, to amplify an
~700bp product from intron 5 of the Fgf8 gene. For sectioning, embryos were fixed overnight
in 4% paraformaldehyde in PBS then dehydrated into 100% methanol. Embryos were then
embedded using the JB-4 Embedding kit as per kit protocol (Polysciences, Inc; Catalog
#00226). Blocks were sectioned at a thickness of 6μM and counterstained with a neutral red
stain. Skeletal preparations were performed as previously described [121]. LysoTracker Red
staining was performed as previously described [122].
Immunohistochemistry
For immunostaining on sections, embryos were embedded in paraffin and 7μM sections were
cut. After dewaxing and rehydration, antigen retrieval was achieved by incubating slides in
0.01M Sodium Citrate pH 6.0 at 95°C (20 min). Each slide was incubated with primary anti-
bodies overnight at 4°C and in secondary antibodies for 1 hour at room temperature and then
counterstained with DAPI (ThermoFisher, D21490). Primary antibodies: Cleaved Caspase-3
(1:100, Cell Signaling, #9661); Phospho-Histone H3 (1:200, Cell Signaling, #9706). Secondary
antibodies: anti-Mouse-488 (1:250, ThermoFisher, A-11017); anti-Rabbit-594 (1:250, Thermo-
Fisher, A11012). All antibodies were diluted in blocking buffer (1% Goat serum in PBS). Con-
focal images were taken and Z-stacks were constructed using imageJ software [123].
Phosphohistone H3 positive and negative nuclei were counted from 3 sections from each of
3 embryos for each genotype and averaged. Percentages represent number of positive nuclei
divided by total nuclei.
Whole mount immunostaining (Neurofilament1) was performed on embryos fixed with 4%
PFA overnight at 4°C, then dehydrated stepwise into methanol and stored at -20°C. Embryos
were bleached in Methanol: 30% Hydrogen Peroxide (5:1), rehydrated and blocked in PBSMT
(2% dried milk, 0.1% Triton x-100 in PBS) for 2 hours at room temperature. Primary antibody
(1:100, DSHB, 2H3 Concentrate) was diluted in PBSMT and incubated overnight at 4°C.
Embryos were then washed 6 x 1 hour and incubated overnight at 4°C with secondary anti-
mouse antibody-488 (1:250, ThermoFisher, A-11017). Embryos were washed and cleared in
50% glycerol before imaging.
Quantitative PCR
The neural tubes were cleanly microdissected with one cut at the anterior side of the last
formed somite and the posterior cut between the neural tube and posterior mesoderm. Dis-
sected tissue were placed in 25μL of Trizol and stored at -80°C. Following genotyping, cDNA
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was synthesized (iScript synthesis kit, BioRad, #1708891) frommRNA extracted from 3–4 neural
tubes. Sybr green reagent with the following primers were used for qPCR: Bmp4 (ACCAATGGA
GCCATTCCGTA, ACGACCATCAGCATTCGGTT), Bmp7 (CTACATGAACGCCACCAA
CC, CACAGCAGGGCTTGGGTAC), Msx1 (CCGTGGATGCAGAGTCCC, GCTTGCGGTT
GGTCTTGTGC), GapDH (TGTAGACCATGTAGTTGAGGTCA, AGGTCGGTGTGAACG
GATTTG). Relative quantification was determined using the delta-delta-CTmethod [124].
Measurements and statistics
Using the measuring tool within Photoshop, linear measurements were made on images of
embryos that were taken at the same magnification; units are in pixels. For all data provided, at
least an n = 3 was used unless otherwise noted. Significance was determined using a two-tailed
t-test unless otherwise noted in the figure legend.
Neural tube ink injections
For determination of NT closure, India ink was diluted 1:10 in PBS and injected into the NT at the
anterior boundary of the hindlimb buds using a pulled glass capillary needle. The posterior neuro-
pore was scored as open if the ink passed through the pore; otherwise it was scored as closed.
BMP4 bead and tail explant cultures
Recombinant mouse BMP4 (R&D Systems, 5020-BP-010) was reconstituted in sterile 4mMHCl
with 0.1% BSA to 100ug/mL as recommended by manufacturer. Affi-Gel Blue Gel beads (50-
100mesh, Bio-Rad;153–7301) were briefly washed with PBS, then soaked in reconstituted BMP4
solution for 1hr at 37°C, then cooled and stored at 4°C and used in experiments for up to 2
weeks. Embryos were harvested from wildtype (NIH-Swiss) animals on the morning of E10.5 in
37°C PBS. Using forceps, the embryos were cut in half at the interlimb region and the rostral
halves were discarded. A small puncture was made with forceps in the dorsal NT at the anterior
boundary of the PSM and a bead was inserted into the lumen of the NT and pushed posteriorly
towards the PSM. Tissues were transferred to a well of a 24-well plate and cultured at 37°C 5%
CO2 in 250μL of defined media [125]: 0.5mL Penicillin-streptomycin (10,000U/mL; Gibco,
15140–122), 1mL non-essential amino acids (Gibco, 11140–035), 1mL sodium pyruvate (Sigma,
S8636), 2mL D-glucose (22.5%), 0.1mL sodium L-ascorbate (0.2g/mL, Sigma, A4034), 1mL cal-
cium lactate hydrate (40mg/mL, Sigma, L4388), 0.1mL D-biotin (0.2mg/mL, Sigma, 47868), vita-
min B12 (40μg/mL, Sigma, V6629), 0.1mL PABA (2mg/mL, Sigma, A9878), to 100mL
Dulbecco’s Modified Eagle Medium (Gibco, 11995). Following incubation, samples where briefly
rinsed with PBS before fixation with 4% paraformaldehyde overnight rocking at 4°C. Samples
were then dehydrated into 100% methanol and stored at -20°C until processed for WISH.
Folic acid injections
For folic acid supplementation, pregnant mothers carrying Fgf3 heterozygous and null embryos
were intraperitoneally injected with 25mg/kg FA at E7.75 and allowed to develop to E9.5.
Supporting Information
S1 Fig. Fgf3 expression is dynamic in the anterior PSM.WISH assay for Fgf3mRNA expres-
sion in WT 29 ss and 30 ss embryos show the absence of an anterior stripe of expression (A, C)
and presence of such a band (B,D) at the same somite stages. Black arrow indicates last somite
boundary, asterisks indicate the 28th somite, note relative position to vessels of the allantois to
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the last somite is also useful to stage embryos (red arrows).
(TIF)
S2 Fig. Fgf3mutant clock oscillation is unaffected. Notch oscillations within the PSM were
examined byHes7mRNA expression in E10.5 controls (A) and Fgf3mutants (B) (33–41 ss).
Measurements of each domain of PSM expression were taken as indicated by the black and
white bars superimposed on the images and data is graphed below. Samples are organized by
phase of oscillation. Note the relative distance between the rostral domain of Hes7 expression
and the last formed somite (indicated by top white bar) is noticeably smaller in Fgf3mutants,
indicative of the formation of smaller somites.
(TIF)
S3 Fig. Somite patterning is unaffected in Fgf3mutants. (A-D) WISH assays for Pax3 (A, B)
and Pax1 (C, D) at 30 ss.
(TIF)
S4 Fig. FGF-responsive gene expression is unaffected in the PSM of Fgf3mutants.WISH
assays for indicated markers at 28 ss (A-D) and 36 ss (E-H’). Dotted lines (E, F, G,H) indicate
relative position of corresponding transverse section (E’, F’, G’,H’). Inset C,D: 46 ss.
(TIF)
S5 Fig. Cell proliferation is not significantly changed in Fgf3mutant mesoderm and com-
pound Fgf3; Bak; Bax triple null homozygote neural tube. Quantification of phospho-his-
tone H3 positive nuclei per total nuclei for Fgf3 Δ/Δmutants and Fgf3 Δ /wt control tailbud (TB)
and neural tube tissues (NT)(A), and neural tube tissue of Fgf3 Δ/Δ; Bak Δ/Δ; Bax Δ/Δmutants
and Fgf3 Δ/Δ; Bak Δ/Δ controls (B)(n = 3 for each genotype, percentage represents positive nuclei
per total nuclei). Error bars represent SEM, no significant differences found using two-tailed t-
test; however, 26–28 ss Fgf3 Δ/Δ; Bak Δ/Δ; Bax Δ/Δmutants had a higher rate of proliferation
trending towards significance (p = 0.13).
(TIF)
S6 Fig. Fgf8intron labels mesoderm progenitor domain. (A) Dorsal view ofWISH assay for
nascent Fgf8 transcript as detected by a probe specific to the fifth intronic region of the Fgf8
coding region (Fgf8intron), showing expression limited to the region of the tailbud progenitors
at E10.5. (B) Sagittal section through Fgf8intron E10.5 tailbud showing expression in the caudal
neuroectoderm and adjacent mesoderm within the chordoneural hinge (box); also note
domain in caudal tail gut (asterisk) (NT: neural tube,No: notochord, GT: gut tube). (C) Utiliz-
ing a probe for the coding regions of Fgf8 (Fgf8exon) labels a majority of the PSM. (D) Diagram
describing Fgf8 expression: 1) Transcription takes place in the PSM progenitors 2) Cells are dis-
placed from the progenitor domain and stop transcribing Fgf8 however 3) Fgf8mRNA per-
dures in these cells distributing the message throughout the PSM.
(TIF)
S7 Fig. Cell death is not required for normal axis extension termination.Homozygous dele-
tion of Bak (Bak Δ/Δ) has minimal effects on cell death in the tailbud at E12.5 and E13.5 (A and B,
lysotracker red staining, lateral view). Bak and Bax double nulls (Bak Δ/Δ; Bax Δ/Δ) however have no
detectable cell death in this domain (D and E) yet form the same number of caudal vertebrae as con-
trols (F and F’, compare toC andC’, E18.5, numbers indicate the number of the caudal vertebra).
(TIF)
S8 Fig. Compound Fgf3; Bak; Bax triple null homozygotes have spina bifida and spina
bifida occulta.Homozygous deletion of Bak in Fgf3mutants (Fgf3 Δ/Δ; Bak Δ/Δ) leads to normal
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spinal development (A, C, E). Homozygous deletion of both Bak and Bax in Fgf3mutants
(Fgf3 Δ/Δ; Bak Δ/Δ; Bax Δ/Δ) causes spina bifida (B, red arrow points to opening in epithelium)
and spina bifida occulta (D, F). Yellow double-headed arrow indicates open neural arches;
bracket in F indicates abnormal gap between neural arches of sacral vertebra 2.
(TIF)
S9 Fig. Noggin expression is unaffected in Fgf3mutants. Lateral view of WISH assay for Nog-
gin expression shows normal expression in mutants (C,D) compared to controls (A, B).
(TIF)
S10 Fig. Neural crest derived dorsal root ganglion patterning is unaffected in Fgf3mutants.
Neurofilament1 (NF1) staining of dorsal root ganglion shows normal patterning in E11.5 Fgf3
mutants (B) compared to littermate controls (A) at the A-P level of 26–34 somites; yellow
arrow indicates posterior edge of hindlimb bud.
(TIF)
S11 Fig.Msx1 expression in the PSM during normal axis extension. Lateral view of WISH
assay forMsx1 in an Fgf3-heterozygous E11.5 (45 ss) embryos showing expression in the dorsal
PSM (arrow).
(TIF)
S12 Fig. Altering BMP signaling affects neural tube width. (A-H) WISH assays for indicated
probes. Note thatMsx1WISH in A and B (dorsal views, 28 ss) and E and F (lateral views, 30
ss) was performed for a relatively short period to reveal qualitative differences in intensity
between genotypes. Transverse sections of 28 ss embryos of indicated genotype (C,D, G, F) are
at the approximate anterior-position of the anterior PSM.
(TIF)
S13 Fig. Bmp4 expression is increased in Fgf3; Bak; Bax triple null homozygotes. Fgf3 Δ/Δ;
Bak Δ/Δ; Bax Δ/Δ triple null homozygotes (B,D) have an increase in Bmp4 expression in the dor-
sal neural tube at 25ss (B) and 36ss (D) as compared to stage-matched littermate Fgf3 Δ/Δ (A)
and Fgf3 Δ/Δ; Bax Δ/WT controls (C). Boxes in A and B indicate area of image enlarged and
placed above whole tail image; red arrowsmark posterior extent of neural tube Bmp4 expres-
sion. Migratory neural crest, marked by FoxD3 expression, are caudally expanded in Fgf3 Δ/Δ;
Bak Δ/Δ; Bax Δ/Δmutants (arrowheads, F and F’) as compared to littermate Fgf3 Δ/Δ; Bak Δ/ Δ
controls (arrowheads, E, and E’). In triple mutants, the premigratory neural crest is expanded
rostrally (red asterisks) although the caudal limit is similar to Fgf3 Δ/Δ; Bak Δ/ Δ littermate con-
trols. (dotted linesmark anterior boundary of PSM).
(TIF)
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